A Pilot Study Assessing the Integrase Inhibitor GSK1349572 in HIV-infected Persons With Virus Resistant to Raltegravir

Clinical trial NCT00950859 · COMPLETED

Trial details

NCT number: NCT00950859
Sponsor: ViiV Healthcare
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Infection, Human Immunodeficiency Virus

Start date: 2009-08-01
Primary completion: 2010-11-01
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.